Mechanism of Inactivation of Escherichia Coli Aspartate Aminotransferase by (S)-4-amino-4,5-dihydro-2-furancarboxylic Acid

Overview

Journal Biochemistry

Specialty Biochemistry

Date 2010 Nov 2

PMID 21033689

Citations 5

Authors

Dali Liu

Edwin Pozharski

Mengmeng Fu

Richard B Silverman

Dagmar Ringe

Affiliations

Soon will be listed here.

Abstract

As a potential drug to treat neurological diseases, the mechanism-based inhibitor (S)-4-amino-4,5-dihydro-2-furancarboxylic acid (S-ADFA) has been found to inhibit the γ-aminobutyric acid aminotransferase (GABA-AT) reaction. To circumvent the difficulties in structural studies of a S-ADFA-enzyme complex using GABA-AT, l-aspartate aminotransferase (l-AspAT) from Escherichia coli was used as a model PLP-dependent enzyme. Crystal structures of the E. coli aspartate aminotransferase with S-ADFA bound to the active site were obtained via cocrystallization at pH 7.5 and 8. The complex structures suggest that S-ADFA inhibits the transamination reaction by forming adducts with the catalytic lysine 246 via a covalent bond while producing 1 equiv of pyridoxamine 5'-phosphate (PMP). Based on the structures, formation of the K246-S-ADFA adducts requires a specific initial binding configuration of S-ADFA in the l-AspAT active site, as well as deprotonation of the ε-amino group of lysine 246 after the formation of the quinonoid and/or ketimine intermediate in the overall inactivation reaction.

Citing Articles

Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions.

Silverman R Chem Rev. 2018; 118(7):4037-4070.

PMID: 29569907 PMC: 8459698. DOI: 10.1021/acs.chemrev.8b00009.

Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5'-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover.

Mascarenhas R, Le H, Clevenger K, Lehrer H, Ringe D, Kelleher N Biochemistry. 2017; 56(37):4951-4961.

PMID: 28816437 PMC: 5624218. DOI: 10.1021/acs.biochem.7b00499.

PLP and GABA trigger GabR-mediated transcription regulation in via external aldimine formation.

Wu R, Sanishvili R, Belitsky B, Juncosa J, Le H, Lehrer H Proc Natl Acad Sci U S A. 2017; 114(15):3891-3896.

PMID: 28348215 PMC: 5393194. DOI: 10.1073/pnas.1703019114.

Design and synthesis of potential mechanism-based inhibitors of the aminotransferase BioA involved in biotin biosynthesis.

Shi C, Aldrich C J Org Chem. 2012; 77(14):6051-8.

PMID: 22724679 PMC: 3448953. DOI: 10.1021/jo3008435.

Mechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in Mycobaterium tuberculosis.

Shi C, Geders T, Park S, Wilson D, Boshoff H, Abayomi O J Am Chem Soc. 2011; 133(45):18194-201.

PMID: 21988601 PMC: 3222238. DOI: 10.1021/ja204036t.

References

Shah S, Shen B, Brunger A . Human ornithine aminotransferase complexed with L-canaline and gabaculine: structural basis for substrate recognition. Structure. 1997; 5(8):1067-75. DOI: 10.1016/s0969-2126(97)00258-x. View

Bryans J, Wustrow D . 3-substituted GABA analogs with central nervous system activity: a review. Med Res Rev. 1999; 19(2):149-77. DOI: 10.1002/(sici)1098-1128(199903)19:2<149::aid-med3>3.0.co;2-b. View

Nanavati S, Silverman R . Design of potential anticonvulsant agents: mechanistic classification of GABA aminotransferase inactivators. J Med Chem. 1989; 32(11):2413-21. DOI: 10.1021/jm00131a001. View

Brunger A, Adams P, Clore G, DeLano W, Gros P, Grosse-Kunstleve R . Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr. 1998; 54(Pt 5):905-21. DOI: 10.1107/s0907444998003254. View

Winn M, Isupov M, Murshudov G . Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr. 2001; 57(Pt 1):122-33. DOI: 10.1107/s0907444900014736. View

Storici P, Capitani G, de Biase D, Moser M, John R, Jansonius J . Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy. Biochemistry. 1999; 38(27):8628-34. DOI: 10.1021/bi990478j. View

Liu D, Pozharski E, Lepore B, Fu M, Silverman R, Petsko G . Inactivation of Escherichia coli L-aspartate aminotransferase by (S)-4-amino-4,5-dihydro-2-thiophenecarboxylic acid reveals "a tale of two mechanisms". Biochemistry. 2007; 46(37):10517-27. DOI: 10.1021/bi700663n. View

Fu M, Silverman R . Isolation and characterization of the product of inactivation of gamma-aminobutyric acid aminotransferase by gabaculine. Bioorg Med Chem. 1999; 7(8):1581-90. DOI: 10.1016/s0968-0896(99)00081-4. View

Silverman R, Andruszkiewicz R, Nanavati S, Taylor C, Vartanian M . 3-Alkyl-4-aminobutyric acids: the first class of anticonvulsant agents that activates L-glutamic acid decarboxylase. J Med Chem. 1991; 34(7):2295-8. DOI: 10.1021/jm00111a053. View

10.

Emsley P, Cowtan K . Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004; 60(Pt 12 Pt 1):2126-32. DOI: 10.1107/S0907444904019158. View

11.

Kiick D, Cook P . pH studies toward the elucidation of the auxiliary catalyst for pig heart aspartate aminotransferase. Biochemistry. 1983; 22(2):375-82. DOI: 10.1021/bi00271a022. View

12.

AMADOR E, Wacker W . Serum glutamic-oxaloacetic transaminase activity. A new modification and an anaytical assessment of current assay technics. Clin Chem. 1962; 8:343-50. View

13.

Storici P, Qiu J, Schirmer T, Silverman R . Mechanistic crystallography. Mechanism of inactivation of gamma-aminobutyric acid aminotransferase by (1R,3S,4S)-3-amino-4-fluorocyclopentane-1-carboxylic acid as elucidated by crystallography. Biochemistry. 2004; 43(44):14057-63. DOI: 10.1021/bi0487185. View

14.

Sarup A, Larsson O, Schousboe A . GABA transporters and GABA-transaminase as drug targets. Curr Drug Targets CNS Neurol Disord. 2003; 2(4):269-77. DOI: 10.2174/1568007033482788. View

15.

John R, Jones E, Fowler L . Enzyme-induced inactivation of transminases by acetylenic and vinyl analogues of 4-aminobutyrate. Biochem J. 1979; 177(2):721-8. PMC: 1186424. DOI: 10.1042/bj1770721. View

16.

Danishefsky A, Onnufer J, Petsko G, Ringe D . Activity and structure of the active-site mutants R386Y and R386F of Escherichia coli aspartate aminotransferase. Biochemistry. 1991; 30(7):1980-5. DOI: 10.1021/bi00221a035. View

17.

Jeffery C, Gloss L, Petsko G, Ringe D . The role of residues outside the active site: structural basis for function of C191 mutants of Escherichia coli aspartate aminotransferase. Protein Eng. 2000; 13(2):105-12. DOI: 10.1093/protein/13.2.105. View

18.

Toney M, KIRSCH J . The K258R mutant of aspartate aminotransferase stabilizes the quinonoid intermediate. J Biol Chem. 1991; 266(35):23900-3. View

19.

Fu M, Silverman R . Inactivation of gamma-aminobutyric acid aminotransferase by (S)-4-amino-4,5-dihydro-2-furancarboxylic acid does not proceed by the expected aromatization mechanism. Bioorg Med Chem Lett. 2003; 14(1):203-6. DOI: 10.1016/j.bmcl.2003.09.065. View

20.

Otwinowski Z, Minor W . Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26. DOI: 10.1016/S0076-6879(97)76066-X. View